Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Diabetes Care|September 23, 2022
Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 DiabetesRandy L Anderson, Linda A DiMeglio, Adrian P Mander, et al.
Statistics in Medicine|July 28, 2017
The Hartung-Knapp modification for random-effects meta-analysis: A useful refinement but are there any residual concerns?Dan Jackson, Martin Law, Gerta Rücker, et al.
Statistical Methods in Medical Research|December 18, 2012
Some recommendations for multi-arm multi-stage trialsJames Wason, Dominic Magirr, Martin Law, et al.
British Journal of Cancer|August 12, 2015
A Bayesian adaptive design for biomarker trials with linked treatmentsJames M S Wason, Jean E Abraham, Richard D Baird, et al.
Obesity (Silver Spring, Md.)|February 19, 2013
Genetic predisposition to an adverse lipid profile limits the improvement in total cholesterol in response to weight lossCelia G Walker, Christina Holzapfel, Ruth J F Loos, et al.
Trials|May 18, 2022
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetesDavid B Dunger, Sylvaine F A Bruggraber, Adrian P Mander, et al.
British Journal of Clinical Pharmacology|July 15, 2023
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participantsMaria B Goncalves, Tim Mant, Jörg Täubel, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
From Microcirculation to Aging-Related Diseases: A Focus on Endothelial SIRT1Martin Law, Pei-Chun Wang, Zhong-Yan Zhou, et al.
BMC Medical Research Methodology|July 29, 2016
Two new methods to fit models for network meta-analysis with random inconsistency effectsMartin Law, Dan Jackson, Rebecca Turner, et al.
Trials|November 6, 2025
Statistical analysis plan for continuous positive airway pressure plus mandibular advancement therapy (PAPMAT): an adaptive randomised crossover trial comparing the benefits and costs of combining two established treatments for obstructive sleep apnoeaMartin Law, Yi-Da Chiu, Sofía S Villar, et al.
Pageof 14